Takeda Pharmaceutical
TAK
#495
Rank
NZ$82.40 B
Marketcap
NZ$24.76
Share price
-0.21%
Change (1 day)
8.56%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$54.42 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total debt is NZ$54.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2025-03-31NZ$53.11 B-0.61%
2024-03-31NZ$53.44 B1.84%
2023-03-31NZ$52.47 B1.95%
2022-03-31NZ$51.47 B-14.12%
2021-03-31NZ$59.93 B-24.71%
2020-03-31NZ$79.60 B4.85%
2019-03-31NZ$75.92 B492.56%
2018-03-31NZ$12.81 B-12.67%
2017-03-31NZ$14.67 B48.67%
2016-03-31NZ$9.86 B20.91%
2015-03-31NZ$8.16 B-15%
2014-03-31NZ$9.60 B29.73%
2013-03-31NZ$7.40 B-7.16%
2012-03-31NZ$7.97 B2364.34%
2011-03-31NZ$0.32 B14.28%
2010-03-31NZ$0.28 B-19.87%
2009-03-31NZ$0.35 B764.47%
2008-03-31NZ$40.87 M-70.36%
2007-03-31NZ$0.13 B-21.9%
2006-03-31NZ$0.17 B-26.93%
2005-03-31NZ$0.24 B14.28%
2004-03-31NZ$0.21 B9.81%
2003-03-31NZ$0.19 B-27.66%
2002-03-31NZ$0.26 B-16.87%
2001-03-31NZ$0.32 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$79.41 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.27 B-18.66%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$105.51 B 93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.52 B 2.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ$0.19 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.14 B-97.90%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$94.65 B 73.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.37 B-23.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$71.74 B 31.82%๐Ÿ‡บ๐Ÿ‡ธ USA